Schott Pharma shares up after Q2 beat

SCHOTT Pharma AG & Co KgaA

11/04/2025 07:46

** Shares in Schott Pharma 1SXP.DE rise 9.7% in early Frankfurt trade after the German pharmaceutical industry supplier reported preliminary Q2 results above market expectations

** Analysts at Jefferies say the results are "running ahead of current market consensus"

** The company said it expected revenues of EUR 252 mln and core earnings (EBITDA) of EUR 72 mln in Q2, compared to a consensus compiled by Vara which saw revenues at EUR 242 mln and EBITDA at EUR 62 mln

** Schott also reiterated its guidance for the full year

 (Reporting by Bernadette Hogg)

 ((bernadette.hogg@thomsonreuters.com))